Robins
Principal executive officer pay for Robins, by year and company, from pay-versus-performance disclosure. Every figure links to its source on the company page.
Adaptive Biotechnologies Corp (ADPT) FY2020–FY2025
Lagged peersTSR -86% vs peer group -1% over FY2020–FY2025
Paid for declineCAP $24,866,836→$39,597,875 while $100 invested went $198.00→$27.00 (FY2020–FY2025)
| Fiscal year | SCT total | Comp actually paid |
|---|---|---|
| FY2020 | $7.1M | $24.9M |
| FY2021 | $8.8M | -$6.2M |
| FY2022 | $8.9M | -$1.1M |
| FY2023 | $8.9M | $2.7M |
| FY2024 | $5.0M | $8.4M |
| FY2025 | $9.1M | $39.6M |
The company's "$100 invested" index ran $198.00 at FY2020 → $27.00 by FY2025 — an annualized return of -32.9%.
Track record
1 measurable tenure in the pay-versus-performance disclosure window. Best annualized TSR: -32.9%/yr at ADPT ( FY2020–FY2025). See the CEO track-record ranking for context.